As a result, we predict that these associated gene signatures will be induced even earlier than GAST itself upon pathologically induced loss of MafA or MAFB, which could be tested temporally in future studies in models of insulin resistance (i.e., following S961 or high-fat diet treatment). The gene discussed is GAST; the disease is Insulin resistance.